Logo image of AVTX

AVALO THERAPEUTICS INC (AVTX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:AVTX - US05338F3064 - Common Stock

15.8 USD
-0.07 (-0.44%)
Last: 12/3/2025, 9:55:28 AM
Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to AVTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 34.39. This target is 117.65% above the current price.
AVTX was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about AVTX.
In the previous month the buy percentage consensus was at a similar level.
AVTX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
AVTX Historical Analyst RatingsAVTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -90 -82 -74 -66 -58 -50 -42 -34 -26 -18 -10 -2 5 10

Price Target & Forecast

Price Low Median Mean High 15.8024.2435.7034.3950.40 - 53.42% 125.95% 117.65% 218.99%
AVTX Current Analyst RatingAVTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-09-29 BTIG Reiterate Buy -> Buy
2025-09-17 HC Wainwright & Co. Maintains Buy -> Buy
2025-08-15 Cantor Fitzgerald Initiate Overweight
2025-03-25 Stifel Initiate Buy
2025-03-25 Jefferies Initiate Buy
2025-03-20 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-02-28 Piper Sandler Initiate Overweight
2024-12-19 BTIG Initiate Buy
2024-12-17 LUCID CAPITAL MARKETS Initiate Buy
2024-10-24 HC Wainwright & Co. Initiate Neutral
2024-04-16 Oppenheimer Upgrade Perform -> Outperform
2023-06-27 Oppenheimer Downgrade Outperform -> Perform
2023-06-27 RBC Capital Downgrade Outperform -> Sector Perform
2023-05-10 RBC Capital Maintains Outperform
2023-02-08 Jefferies Downgrade Hold -> Underperform
2022-03-03 RBC Capital Maintains Outperform
2022-03-03 Jefferies Downgrade Buy -> Hold
2021-09-24 RBC Capital Initiate Outperform

AVALO THERAPEUTICS INC / AVTX FAQ

Can you provide the average price target for AVALO THERAPEUTICS INC stock?

15 analysts have analysed AVTX and the average price target is 34.39 USD. This implies a price increase of 117.65% is expected in the next year compared to the current price of 15.8.


How do analysts rate AVALO THERAPEUTICS INC (AVTX)?

The consensus rating for AVALO THERAPEUTICS INC (AVTX) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.